Runx1 is required for hematopoietic defects and leukemogenesis in Cbfb-MYH11 knock-in mice

Leukemia

Volumn 29, Issue 8, 2015, Pages 1771-1778

  Hyde, R K ^a   Zhao, L ^a   Alemu, L ^a   Liu, P P ^a,b  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CBFB MYH11 FUSION PROTEIN; CORE BINDING FACTOR BETA; CORE BINDING FACTOR BETA SMOOTH MUSCLE MYOSIN HEAVY CHAIN; HYBRID PROTEIN; MYOSIN; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG; CBFB PROTEIN, MOUSE; MYOSIN 11, MOUSE; MYOSIN HEAVY CHAIN; RUNX1 PROTEIN, MOUSE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE FUNCTION; GENE LOSS; GENE REPRESSION; HEMATOPOIESIS; HOMOZYGOSITY; LEUKEMIA; LEUKEMOGENESIS; MOUSE; NONHUMAN; NULL ALLELE; PRIORITY JOURNAL; PROTEIN BINDING; ANIMAL; APOPTOSIS; CELL CULTURE; FLOW CYTOMETRY; GENE TARGETING; HUMAN; IMMUNOPRECIPITATION; METABOLISM; MORTALITY; PATHOLOGY; PHYSIOLOGY; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 2 SUBUNIT; CORE BINDING FACTOR BETA SUBUNIT; FLOW CYTOMETRY; GENE KNOCK-IN TECHNIQUES; HEMATOPOIESIS; HUMANS; IMMUNOPRECIPITATION; LEUKEMIA; MICE; MYOSIN HEAVY CHAINS;

EID: 84938957980     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2015.58     Document Type: Article

References (34)

1. Look AT. Oncogenic transcription factors in the human acute leukemias. Science 1997; 278: 1059-1064.
2. Le Beau MM, Larson RA, Bitter MA, Vardiman JW, Golomb HM, Rowley JD. Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association. N Engl J Med 1983; 309: 630-636.
3. Liu P, Tarle SA, Hajra A, Claxton DF, Marlton P, Freedman M et al. Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. Science 1993; 261: 1041-1044.
4. Liu PP, Wijmenga C, Hajra A, Blake TB, Kelley CA, Adelstein RS et al. Identification of the chimeric protein product of the CBFB-MYH11 fusion gene in inv(16) leukemia cells. Genes Chromosomes Cancer 1996; 16: 77-87.
5. Castilla LH, Garrett L, Adya N, Orlic D, Dutra A, Anderson S et al. The fusion gene Cbfb-MYH11 blocks myeloid differentiation and predisposes mice to acute myelomonocytic leukaemia [letter]. Nat Genet 1999; 23: 144-146.
6. Castilla LH, Perrat P, Martinez NJ, Landrette SF, Keys R, Oikemus S et al. Identification of genes that synergize with Cbfb-MYH11 in the pathogenesis of acute myeloid leukemia. Proc Natl Acad Sci USA 2004; 101: 4924-4929.
7. Chuang LS, Ito K, Ito Y. RUNX family: regulation and diversification of roles through interacting proteins. Int J Cancer 2013; 132: 1260-1271.
8. Tang YY, Shi J, Zhang L, Davis A, Bravo J, Warren AJ et al. Energetic and functional contribution of residues in the core binding factor beta (CBFbeta) subunit to heterodimerization with CBFalpha. J Biol Chem 2000; 275: 39579-39588.
9. Lukasik SM, Zhang L, Corpora T, Tomanicek S, Li Y, Kundu M et al. Altered affinity of CBF beta-SMMHC for Runx1 explains its role in leukemogenesis. Nat Struct Biol 2002; 9: 674-679.
10. Durst KL, Lutterbach B, Kummalue T, Friedman AD, Hiebert SW. The inv(16) fusion protein associates with corepressors via a smooth muscle myosin heavy-chain domain. Mol Cell Biol 2003; 23: 607-619.
11. Lutterbach B, Hou Y, Durst KL, Hiebert SW. The inv(16) encodes an acute myeloid leukemia 1 transcriptional corepressor. Proc Natl Acad Sci USA 1999; 96: 12822-12827.
12. Adya N, Stacy T, Speck NA, Liu PP. The leukemic protein core binding factor beta (CBFbeta)-smooth-muscle myosin heavy chain sequesters CBFalpha2 into cytoskeletal filaments and aggregates. Mol Cell Biol 1998; 18: 7432-7443.
13. Castilla LH, Wijmenga C, Wang Q, Stacy T, Speck NA, Eckhaus M et al. Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11. Cell 1996; 87: 687-696.
14. Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 1996; 84: 321-330.
15. Wang Q, Stacy T, Binder M, Marin-Padilla M, Sharpe AH, Speck NA. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc Natl Acad Sci USA 1996; 93: 3444-3449.
16. Wang Q, Stacy T, Miller JD, Lewis AF, Gu TL, Huang X et al. The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo. Cell 1996; 87: 697-708.
17. Niki M, Okada H, Takano H, Kuno J, Tani K, Hibino H et al. Hematopoiesis in the fetal liver is impaired by targeted mutagenesis of a gene encoding a non-DNA binding subunit of the transcription factor, polyomavirus enhancer binding protein 2/core binding factor. Proc Natl Acad Sci USA 1997; 94: 5697-5702.
18. Sasaki K, Yagi H, Bronson RT, Tominaga K, Matsunashi T, Deguchi K et al. Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor beta. Proc Natl Acad Sci USA 1996; 93: 12359-12363.
19. Hyde RK, Kamikubo Y, Anderson S, Kirby M, Alemu L, Zhao L et al. Cbfb/Runx1 repression-independent blockage of differentiation and accumulation of Csf2rb-expressing cells by Cbfb-MYH11. Blood 2010; 115: 1433-1443.
20. Kamikubo Y, Zhao L, Wunderlich M, Corpora T, Hyde RK, Paul TA et al. Accelerated leukemogenesis by truncated CBF beta-SMMHC defective in high-affinity binding with RUNX1. Cancer Cell 2010; 17: 455-468.
21. Kamikubo Y, Hyde RK, Zhao L, Alemu L, Rivas C, Garrett LJ et al. The C-terminus of CBFbeta-SMMHC is required to induce embryonic hematopoietic defects and leukemogenesis. Blood 2013; 121: 638-642.
22. Cunningham L, Finckbeiner S, Hyde RK, Southall N, Marugan J, Yedavalli VR et al. Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBFbeta interaction. Proc Natl Acad Sci USA 2012; 109: 14592-14597.
23. Kuo YH, Landrette SF, Heilman SA, Perrat PN, Garrett L, Liu PP et al. Cbf beta-SMMHC induces distinct abnormal myeloid progenitors able to develop acute myeloid leukemia. Cancer Cell 2006; 9: 57-68.
24. North T, Gu TL, Stacy T, Wang Q, Howard L, Binder M et al. Cbfa2 is required for the formation of intra-aortic hematopoietic clusters. Development 1999; 126: 2563-2575.
25. Lewandoski M, Meyers EN, Martin GR. Analysis of Fgf8 gene function in vertebrate development. Cold Spring Harb Symp Quant Biol 1997; 62: 159-168.
26. Kuhn R, Schwenk F, Aguet M, Rajewsky K. Inducible gene targeting in mice. Science 1995; 269: 1427-1429.
27. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat methods 2012; 9: 671-675.
28. Yokomizo T, Hasegawa K, Ishitobi H, Osato M, Ema M, Ito Y et al. Runx1 is involved in primitive erythropoiesis in the mouse. Blood 2008; 111: 4075-4080.
29. Growney JD, Shigematsu H, Li Z, Lee BH, Adelsperger J, Rowan R et al. Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. Blood 2005; 106: 494-504.
30. Rhoades KL, Hetherington CJ, Rowley JD, Hiebert SW, Nucifora G, Tenen DG et al. Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute to leukemogenesis. Proc Natl Acad Sci USA 1996; 93: 11895-11900.
31. Mandoli A, Singh AA, Jansen PW, Wierenga AT, Riahi H, Franci G et al. CBFB-MYH11/RUNX1 together with a compendium of hematopoietic regulators, chromatin modifiers and basal transcription factors occupies self-renewal genes in inv(16) acute myeloid leukemia. Leukemia 2013; 28: 770-778.
32. Ben-Ami O, Friedman D, Leshkowitz D, Goldenberg D, Orlovsky K, Pencovich N et al. Addiction of t(8;21) and inv(16) acute myeloid leukemia to native RUNX1. Cell Rep 2013; 4: 1131-1143.
33. Goyama S, Schibler J, Cunningham L, Zhang Y, Rao Y, Nishimoto N et al. Transcription factor RUNX1 promotes survival of acute myeloid leukemia cells. J Clin Invest 2013; 123: 3876-3888.
34. Tang JL, Hou HA, Chen CY, Liu CY, Chou WC, Tseng MH et al. AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations. Blood 2009; 114: 5352-5361.